Leping Li
- Molecular Biology top 0.5%
- RNA modifications and cancer 16
- Genomics and Chromatin Dynamics 15
- Connexins and lens biology 13
- Gene expression and cancer classification 13
- RNA Research and Splicing 12
- Epigenetics and DNA Methylation 11
- RNA and protein synthesis mechanisms 9
- Cancer Research top 1%
- Biochemistry top 1%
- Oncology top 2%
- Pharmacology top 1%
-
- Estrogen and related hormone effects 8
- Co-authors
- Lee G. PedersenWeichun HuangGábor MarthJason R. MyersThomas A. DardenClarice R. WeinbergL. PereraTom Darden
- Journals
- Bioorganic & Medicinal Chemistry Letters (13 papers)Bioinformatics (10 papers)Journal of Biological Chemistry (7 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Leping Li
172 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 187
- Molecular Biology 6.9k
- Cancer Research 1.2k
- Biochemistry 459
- Oncology 1.4k
- Pharmacology 365
Countries citing papers authored by Leping Li
This map shows the geographic impact of Leping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leping Li more than expected).
Fields of papers citing papers by Leping Li
This network shows the impact of papers produced by Leping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leping Li. The network helps show where Leping Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 3 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 2 | |
| 5 | 2021 | 29 | |
| 6 | 2021 | 13 | |
| 7 | 2019 | 43 | |
| 8 | 2018 | 12 | |
| 9 | 2018 | 11 | |
| 10 | Tetrandrine reverses the drug resistance of colon cancer to 5-fluorouracil | 2017 | 2 |
| 11 | 2015 | 21 | |
| 12 | 2015 | 48 | |
| 13 | 2014 | 2 | |
| 14 | 2014 | 27 | |
| 15 | 2007 | 138 | |
| 16 | 2006 | 14 | |
| 17 | 2004 | 150 | |
| 18 | 1996 | 2 | |
| 19 | 1995 | 9 | |
| 20 | 1992 | 35 |
About Leping Li
Leping Li is a scholar working on Molecular Biology, Endocrine and Autonomic Systems, Cancer Research, Reproductive Medicine and Pharmacology, having authored 178 papers that have together received 10.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (16 papers), Genomics and Chromatin Dynamics (15 papers), Connexins and lens biology (13 papers), Gene expression and cancer classification (13 papers), RNA Research and Splicing (12 papers), Epigenetics and DNA Methylation (11 papers), RNA and protein synthesis mechanisms (9 papers) and Estrogen and related hormone effects (8 papers). The work is most often cited by research in Molecular Biology (6.9k citations), Cancer Research (1.2k citations), Biochemistry (459 citations), Oncology (1.4k citations) and Pharmacology (365 citations). Leping Li has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Lee G. Pedersen, Weichun Huang, Gábor Marth, Jason R. Myers, Thomas A. Darden, Clarice R. Weinberg, L. Perera, Tom Darden, David M. Umbach and Julio C. Medina. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Bioinformatics, Journal of Biological Chemistry, BMC Genomics and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.